American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Redhill Biopharma Ltd.

RDHL Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

RDHL historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of RDHL by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
RDHL Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
RDHL Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
RDHL Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in RDHL holdings by institutional investors

Insider Trading

Quarterly net insider trading by RDHL's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Revolving Door

Former government officials who have lobbied for RDHL

Quiver Logo

No former government officials on record as having lobbied for RDHL

Revolving Door Dashboard
Corporate Lobbying

RDHL Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
Revenue Breakdown

RDHL Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
RDHL Income Statement
RDHL Balance Sheet
RDHL Cash Flow
U.S. Patents

New RDHL patent grants

  • Patent Title: Method for eradicating helicobacter pylori infection in patients regardless of body mass index Mar. 10, 2026
  • Patent Title: Sphingosine kinase 2 inhibitor for treating coronavirus infection Feb. 17, 2026
  • Patent Title: Serine protease inhibitor for treating coronavirus infection Dec. 23, 2025
  • Patent Title: Therapy for inhibition of single-stranded rna virus replication Jul. 29, 2025
  • Patent Title: Biomarkers of coronavirus pneumonia Oct. 15, 2024
  • Patent Title: All-in-one fixed-dose combination for treating Mar. 19, 2024
  • Patent Title: Serine protease inhibitor for treating coronavirus infection Mar. 05, 2024
  • Patent Title: Method for eradicating Jan. 23, 2024
  • Patent Title: Inhibitor of sphingosine kinase 2 for treating ebola Oct. 17, 2023
  • Patent Title: Combination compositions for treatment of cancer Apr. 25, 2023
  • Patent Title: Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections Feb. 28, 2023
  • Patent Title: Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia Oct. 18, 2022
  • Patent Title: Sphingosine kinase 2 inhibitor for treating coronavirus infection Jun. 21, 2022
  • Patent Title: Rifabutin-based compositions and methods for treating Oct. 05, 2021
  • Patent Title: Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine Aug. 17, 2021
  • Patent Title: Compositions for treating ebola virus infection Aug. 17, 2021
  • Patent Title: Formulations and methods of manufacturing formulations for use in colonic evacuation Jul. 13, 2021
  • Patent Title: Sphingosine kinase 2 inhibitor for treating coronavirus infection Jul. 06, 2021
  • Patent Title: Serine protease inhibitor for treating coronavirus infection Jun. 29, 2021
  • Patent Title: Method for treating cancer with combination therapy Mar. 16, 2021
  • Patent Title: Methods for treating helicobacter pylori infection Jan. 26, 2021
  • Patent Title: Method for treating crohn's disease using triple antimicrobial all-in-one formulation Sep. 08, 2020
  • Patent Title: Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome Jun. 02, 2020
  • Patent Title: Blister package May. 12, 2020
  • Patent Title: Therapy for inhibition of single-stranded rna virus replication Jan. 28, 2020
  • Patent Title: Formulations and methods of manufacturing formulations for use in colonic evacuation Dec. 03, 2019
  • Patent Title: Combination therapies for treating cancer Nov. 05, 2019
  • Patent Title: Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics Oct. 08, 2019
  • Patent Title: Pharmaceutical compositions for the treatment of Mar. 26, 2019
  • Patent Title: Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine Dec. 04, 2018
  • Patent Title: Therapy for inhibition of single-stranded rna virus replication May. 22, 2018
  • Patent Title: Composition and method for treating an autoimmune disease Feb. 27, 2018
  • Patent Title: Combination therapies for treating cancer Dec. 19, 2017
  • Patent Title: Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms Jun. 13, 2017
  • Patent Title: Antiemetic extended release solid dosage forms May. 02, 2017
  • Patent Title: Pharmaceutical compositions for the treatment of Mar. 28, 2017
  • Patent Title: Pharmaceutical compositions for the treatment of Nov. 22, 2016
  • Patent Title: Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof Apr. 19, 2016
  • Patent Title: Methods and compositions comprising rifabutin, clarithromycin, and clofazimine Dec. 01, 2015
  • Patent Title: Methods and compositions for treating inflammatory bowel disease Jul. 07, 2015
  • Patent Title: Pharmaceutical compositions for the treatment of Jun. 09, 2015
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to RDHL from public contracts

RDHL News

Recent insights relating to RDHL

CNBC Recommendations

Recent picks made for RDHL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RDHL

RDHL Analyst Ratings

RDHL Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
RDHL Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $RDHL stock a Buy, Sell, or Hold?

  • What is the price target for $RDHL stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

RDHL Top Shareholders
Shareholder
Shares Held
RDHL Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $RDHL stock?

  • Who owns the most shares of $RDHL stock?

  • What funds own $RDHL stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

RDHL Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view RDHL Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About RDHL

RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.

Redhill Biopharma Ltd. (RDHL) Historical Stock Prices

Redhill Biopharma Ltd. (RDHL) closed at $0.5204 on September 24, 2026. Over the past year its adjusted close ranged from $0.5204 to $2.52. Daily prices go back to January 2, 2014, 3,196 trading days in all.

  • 1 month-14.00%
  • 3 months-39.50%
  • Year to date-49.48%
  • 1 year-68.84%
  • 3 years-96.78%
  • 5 years-99.99%
  • Max-100.00%
See every congressional and insider trade on the RDHL price chart

Quiver Premium charts RDHL's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 0.5432 0.5557 0.5200 0.5204 0.5204 90,703
Sep 23, 2026 0.5300 0.5500 0.5240 0.5431 0.5431 80,294
Sep 22, 2026 0.5450 0.5682 0.5199 0.5410 0.5410 204,317
Sep 21, 2026 0.5600 0.5679 0.5385 0.5499 0.5499 78,284
Sep 18, 2026 0.5796 0.5900 0.5600 0.5683 0.5683 84,986
Sep 17, 2026 0.5700 0.5999 0.5700 0.5928 0.5928 230,827
Sep 16, 2026 0.5700 0.5801 0.5405 0.5500 0.5500 222,417
Sep 15, 2026 0.6000 0.6000 0.5600 0.5751 0.5751 252,918
Sep 14, 2026 0.6200 0.6200 0.5900 0.6139 0.6139 208,612
Sep 11, 2026 0.6550 0.6799 0.6200 0.6449 0.6449 265,854
Sep 10, 2026 0.7000 0.7000 0.6533 0.6533 0.6533 153,030
Sep 9, 2026 0.6500 0.7097 0.6500 0.6964 0.6964 231,757
Sep 8, 2026 0.7170 0.7300 0.6500 0.6500 0.6500 407,026
Sep 4, 2026 0.7400 0.7688 0.6997 0.7244 0.7244 581,419
Sep 3, 2026 0.7381 0.7777 0.7017 0.7128 0.7128 446,144
Sep 2, 2026 0.8444 0.8822 0.7210 0.7410 0.7410 1,439,476
Sep 1, 2026 0.8820 0.9000 0.7800 0.8700 0.8700 3,825,614
Aug 31, 2026 1.36 1.60 0.9000 0.9000 0.9000 104,018,946
Aug 28, 2026 0.6351 0.7000 0.6202 0.6610 0.6610 42,434
Aug 27, 2026 0.5952 0.6300 0.5931 0.6300 0.6300 37,883
Aug 26, 2026 0.6050 0.6277 0.6046 0.6153 0.6153 16,635
Aug 25, 2026 0.6136 0.6136 0.6000 0.6051 0.6051 4,997
Aug 24, 2026 0.6376 0.6376 0.6022 0.6052 0.6052 11,940
Aug 21, 2026 0.6120 0.6500 0.6000 0.6300 0.6300 19,484
Aug 20, 2026 0.6200 0.6500 0.6200 0.6250 0.6250 15,436
Aug 19, 2026 0.5804 0.6329 0.5804 0.6280 0.6280 25,491
Aug 18, 2026 0.5801 0.6020 0.5700 0.5929 0.5929 39,651
Aug 17, 2026 0.6000 0.6099 0.5820 0.5850 0.5850 31,972
Aug 14, 2026 0.5850 0.6042 0.5801 0.5999 0.5999 8,509
Aug 13, 2026 0.5810 0.6298 0.5807 0.5950 0.5950 25,418
Aug 12, 2026 0.6105 0.6198 0.5809 0.5900 0.5900 21,342
Aug 11, 2026 0.6200 0.6419 0.5902 0.6000 0.6000 11,534
Aug 10, 2026 0.6049 0.6496 0.5810 0.5810 0.5810 47,834
Aug 7, 2026 0.6480 0.6480 0.5817 0.6050 0.6050 54,405
Aug 6, 2026 0.6800 0.6800 0.5799 0.5810 0.5810 58,690
Aug 5, 2026 0.6302 0.6752 0.6302 0.6700 0.6700 22,737
Aug 4, 2026 0.6700 0.6994 0.6338 0.6479 0.6479 18,412
Aug 3, 2026 0.6500 0.6567 0.6484 0.6502 0.6502 21,459
Jul 31, 2026 0.6867 0.6867 0.6351 0.6500 0.6500 12,370
Jul 30, 2026 0.6831 0.7094 0.6300 0.6307 0.6307 64,988
Jul 29, 2026 0.7010 0.7149 0.6610 0.6828 0.6828 95,902
Jul 28, 2026 0.7200 0.7300 0.6500 0.7300 0.7300 123,270
Jul 27, 2026 0.6500 0.7099 0.6500 0.7000 0.7000 27,740
Jul 24, 2026 0.6900 0.6999 0.6300 0.6333 0.6333 20,220
Jul 23, 2026 0.6900 0.7145 0.6619 0.6682 0.6682 4,483
Jul 22, 2026 0.7100 0.7202 0.6851 0.6851 0.6851 26,858
Jul 21, 2026 0.7200 0.7250 0.6885 0.6900 0.6900 46,993
Jul 20, 2026 0.7319 0.7500 0.7000 0.7000 0.7000 54,642
Jul 17, 2026 0.7340 0.7800 0.7050 0.7050 0.7050 70,024
Jul 16, 2026 0.7431 0.7590 0.7300 0.7310 0.7310 12,090
Jul 15, 2026 0.7400 0.7900 0.7400 0.7431 0.7431 268,965
Jul 14, 2026 0.7200 0.7540 0.7200 0.7390 0.7390 75,056
Jul 13, 2026 0.7100 0.7220 0.6370 0.6930 0.6930 154,155
Jul 10, 2026 0.6973 0.7598 0.6850 0.6950 0.6950 38,212
Jul 9, 2026 0.7204 0.7500 0.6850 0.7015 0.7015 55,612
Jul 8, 2026 0.7500 0.7500 0.6930 0.7100 0.7100 59,375
Jul 7, 2026 0.7810 0.8171 0.7358 0.7358 0.7358 94,948
Jul 6, 2026 0.8360 0.8799 0.7770 0.7900 0.7900 72,534
Jul 2, 2026 0.8800 0.8899 0.8100 0.8122 0.8122 41,699
Jul 1, 2026 0.8500 0.8999 0.8101 0.8299 0.8299 50,882
Jun 30, 2026 0.8601 0.9150 0.8280 0.8450 0.8450 48,043
Jun 29, 2026 0.9000 0.9300 0.8600 0.8601 0.8601 101,654
Jun 26, 2026 0.8600 0.9429 0.8600 0.8786 0.8786 72,908
Jun 25, 2026 0.8700 0.8833 0.8600 0.8601 0.8601 30,511
Jun 24, 2026 0.9000 0.9260 0.8600 0.9090 0.9090 28,946
Jun 23, 2026 0.8350 0.9399 0.8300 0.9260 0.9260 126,483
Jun 22, 2026 0.8250 0.8700 0.8101 0.8400 0.8400 161,589
Jun 18, 2026 0.7920 0.8650 0.7800 0.8138 0.8138 677,965
Jun 17, 2026 0.8000 0.8049 0.7800 0.7850 0.7850 56,595
Jun 16, 2026 0.8000 0.8400 0.7800 0.7910 0.7910 144,540
Jun 15, 2026 0.8300 0.8400 0.7900 0.8300 0.8300 1,118,321
Jun 12, 2026 0.8950 0.8950 0.7800 0.8100 0.8100 190,399
Jun 11, 2026 0.8900 0.9300 0.8800 0.9210 0.9210 322,333
Jun 10, 2026 0.8000 0.9300 0.8000 0.8800 0.8800 316,525
Jun 9, 2026 0.9000 0.9100 0.8000 0.8001 0.8001 5,937,633
Jun 8, 2026 1.03 1.03 0.9508 1.02 1.02 150,665
Jun 5, 2026 0.9332 1.06 0.9332 1.03 1.03 63,099
Jun 4, 2026 0.9900 1.02 0.9155 1.00 1.00 114,586
Jun 3, 2026 1.00 1.06 0.9454 1.00 1.00 169,076
Jun 2, 2026 1.02 1.03 0.9800 1.01 1.01 172,717
Jun 1, 2026 0.9900 1.02 0.9801 1.00 1.00 24,942
May 29, 2026 0.9997 1.02 0.9601 1.00 1.00 32,938
May 28, 2026 1.02 1.02 0.9700 1.00 1.00 29,051
May 27, 2026 1.02 1.09 0.9900 1.01 1.01 119,291
May 26, 2026 0.9701 1.02 0.9599 1.01 1.01 90,146
May 22, 2026 0.9200 1.00 0.9100 0.9798 0.9798 58,922
May 21, 2026 0.9100 0.9499 0.9000 0.9350 0.9350 18,424
May 20, 2026 0.9100 0.9279 0.9001 0.9190 0.9190 64,743
May 19, 2026 0.9498 0.9499 0.9002 0.9281 0.9281 49,004
May 18, 2026 1.04 1.07 0.9000 0.9335 0.9335 951,270
May 15, 2026 1.00 1.03 0.9801 1.03 1.03 100,627
May 14, 2026 1.01 1.02 0.9900 1.02 1.02 10,749
May 13, 2026 0.9950 1.04 0.9606 0.9900 0.9900 55,760
May 12, 2026 1.00 1.02 0.9700 1.02 1.02 17,019
May 11, 2026 0.9503 1.03 0.9503 1.03 1.03 24,788
May 8, 2026 1.01 1.02 0.9600 1.01 1.01 20,020
May 7, 2026 1.01 1.04 0.9800 1.01 1.01 77,341
May 6, 2026 1.02 1.05 1.01 1.02 1.02 23,307
May 5, 2026 1.02 1.04 0.9326 1.02 1.02 278,986
May 4, 2026 1.09 1.09 1.04 1.04 1.04 41,308
May 1, 2026 1.10 1.10 1.06 1.08 1.08 17,939
Apr 30, 2026 1.06 1.10 1.05 1.09 1.09 32,110
Apr 29, 2026 1.01 1.04 1.01 1.04 1.04 28,946
Apr 28, 2026 1.03 1.07 1.01 1.04 1.04 74,317
Apr 27, 2026 1.02 1.05 1.01 1.03 1.03 36,439
Apr 24, 2026 1.03 1.07 1.01 1.02 1.02 82,291
Apr 23, 2026 0.8190 1.06 0.8190 1.03 1.03 268,610
Apr 22, 2026 0.8237 0.8550 0.8237 0.8466 0.8466 58,162
Apr 21, 2026 0.8190 0.8200 0.7851 0.8000 0.8000 32,718
Apr 20, 2026 0.8200 0.8200 0.7805 0.7905 0.7905 10,649
Apr 17, 2026 0.8350 0.8350 0.7803 0.8021 0.8021 56,099
Apr 16, 2026 0.8365 0.8544 0.7835 0.7845 0.7845 12,822
Apr 15, 2026 0.8100 0.8400 0.8100 0.8130 0.8130 15,740
Apr 14, 2026 0.8490 0.8490 0.8000 0.8100 0.8100 22,195
Apr 13, 2026 0.8102 0.8319 0.7802 0.8130 0.8130 47,115
Apr 10, 2026 0.8753 0.8753 0.8102 0.8251 0.8251 26,186
Apr 9, 2026 0.8450 0.8600 0.8138 0.8311 0.8311 10,929
Apr 8, 2026 0.8100 0.8100 0.7969 0.7999 0.7999 25,391
Apr 7, 2026 0.8100 0.8150 0.8000 0.8000 0.8000 10,723
Apr 6, 2026 0.8370 0.8599 0.8000 0.8291 0.8291 29,858
Apr 2, 2026 0.8106 0.8206 0.7850 0.7994 0.7994 12,910
Apr 1, 2026 0.7500 0.8382 0.7500 0.8131 0.8131 25,410
Mar 31, 2026 0.7600 0.7611 0.7106 0.7452 0.7452 25,995
Mar 30, 2026 0.7900 0.7900 0.7101 0.7447 0.7447 51,295
Mar 27, 2026 0.8299 0.8299 0.7500 0.7500 0.7500 28,646
Mar 26, 2026 0.8340 0.8650 0.7801 0.7811 0.7811 31,182
Mar 25, 2026 0.8722 0.8899 0.8402 0.8899 0.8899 19,334
Mar 24, 2026 0.8899 0.8899 0.8700 0.8899 0.8899 7,608
Mar 23, 2026 0.9000 0.9000 0.8375 0.8749 0.8749 11,862
Mar 20, 2026 0.8550 0.8800 0.8510 0.8790 0.8790 6,538
Mar 19, 2026 0.8800 0.8878 0.8500 0.8878 0.8878 9,150
Mar 18, 2026 0.8860 0.8860 0.8300 0.8447 0.8447 12,306
Mar 17, 2026 0.8578 0.8750 0.8402 0.8750 0.8750 27,208
Mar 16, 2026 0.8438 0.8528 0.8401 0.8528 0.8528 8,517
Mar 13, 2026 0.8669 0.9000 0.8669 0.8700 0.8700 8,941
Mar 12, 2026 0.8400 0.9200 0.8000 0.8800 0.8800 84,479
Mar 11, 2026 0.8800 0.8901 0.8576 0.8787 0.8787 42,884
Mar 10, 2026 0.9400 0.9400 0.8820 0.9000 0.9000 37,318
Mar 9, 2026 0.9200 0.9499 0.9000 0.9241 0.9241 8,415
Mar 6, 2026 0.9395 0.9546 0.9100 0.9200 0.9200 14,517
Mar 5, 2026 0.9600 0.9700 0.9146 0.9455 0.9455 29,100
Mar 4, 2026 0.9500 0.9500 0.9001 0.9400 0.9400 11,514
Mar 3, 2026 0.9200 0.9500 0.8801 0.9500 0.9500 50,069
Mar 2, 2026 0.9700 0.9700 0.9100 0.9299 0.9299 58,633
Feb 27, 2026 0.9800 0.9900 0.9325 0.9700 0.9700 18,302
Feb 26, 2026 0.9900 1.00 0.9519 0.9800 0.9800 24,049
Feb 25, 2026 1.00 1.07 0.9500 0.9600 0.9600 365,323
Feb 24, 2026 0.9801 1.02 0.9801 0.9900 0.9900 19,599
Feb 23, 2026 0.9800 1.00 0.9500 0.9600 0.9600 18,343
Feb 20, 2026 1.00 1.02 0.9800 0.9830 0.9830 18,180
Feb 19, 2026 0.9800 1.06 0.9800 1.03 1.03 16,064
Feb 18, 2026 1.06 1.06 0.9950 0.9950 0.9950 7,425
Feb 17, 2026 1.02 1.04 0.9814 1.02 1.02 31,022
Feb 13, 2026 1.02 1.07 0.9801 1.00 1.00 30,737
Feb 12, 2026 1.01 1.02 0.9600 0.9852 0.9852 9,334
Feb 11, 2026 0.9910 0.9944 0.9600 0.9600 0.9600 21,374
Feb 10, 2026 1.10 1.10 0.9600 0.9976 0.9976 85,231
Feb 9, 2026 1.07 1.07 1.00 1.05 1.05 27,652
Feb 6, 2026 1.05 1.11 1.03 1.07 1.07 37,222
Feb 5, 2026 1.09 1.10 1.00 1.03 1.03 46,296
Feb 4, 2026 1.13 1.15 1.04 1.06 1.06 60,161
Feb 3, 2026 1.15 1.17 1.11 1.12 1.12 35,395
Feb 2, 2026 1.22 1.22 1.15 1.15 1.15 61,392
Jan 30, 2026 1.22 1.30 1.20 1.22 1.22 31,584
Jan 29, 2026 1.25 1.28 1.20 1.27 1.27 42,101
Jan 28, 2026 1.31 1.33 1.27 1.29 1.29 21,516
Jan 27, 2026 1.37 1.37 1.26 1.33 1.33 81,659
Jan 26, 2026 1.31 1.35 1.29 1.31 1.31 15,940
Jan 23, 2026 1.31 1.36 1.30 1.36 1.36 27,563
Jan 22, 2026 1.31 1.39 1.30 1.33 1.33 134,649
Jan 21, 2026 1.32 1.39 1.29 1.35 1.35 322,886
Jan 20, 2026 1.30 1.39 1.30 1.31 1.31 69,466
Jan 16, 2026 1.27 1.39 1.27 1.36 1.36 86,709
Jan 15, 2026 1.20 1.33 1.20 1.31 1.31 103,729
Jan 14, 2026 1.25 1.25 1.21 1.23 1.23 84,668
Jan 13, 2026 1.26 1.26 1.20 1.24 1.24 22,357
Jan 12, 2026 1.25 1.28 1.17 1.27 1.27 155,017
Jan 9, 2026 1.33 1.35 1.25 1.27 1.27 75,176
Jan 8, 2026 1.22 1.38 1.22 1.34 1.34 237,628
Jan 7, 2026 1.31 1.38 1.21 1.22 1.22 294,767
Jan 6, 2026 1.34 1.41 1.30 1.37 1.37 715,012
Jan 5, 2026 1.20 1.42 1.19 1.40 1.40 24,698,390
Jan 2, 2026 1.04 1.06 1.02 1.03 1.03 33,015
Dec 31, 2025 1.00 1.04 0.9050 1.03 1.03 318,832
Dec 30, 2025 1.06 1.08 1.03 1.03 1.03 62,980
Dec 29, 2025 1.11 1.15 1.06 1.09 1.09 59,805
Dec 26, 2025 1.18 1.18 1.13 1.14 1.14 25,804
Dec 24, 2025 1.18 1.21 1.15 1.15 1.15 72,517
Dec 23, 2025 1.10 1.23 1.10 1.19 1.19 200,158
Dec 22, 2025 1.14 1.18 1.14 1.15 1.15 22,905
Dec 19, 2025 1.18 1.20 1.17 1.18 1.18 20,372
Dec 18, 2025 1.17 1.20 1.15 1.15 1.15 51,786
Dec 17, 2025 1.22 1.24 1.16 1.17 1.17 36,217
Dec 16, 2025 1.24 1.24 1.19 1.21 1.21 61,886
Dec 15, 2025 1.22 1.22 1.14 1.19 1.19 185,461
Dec 12, 2025 1.22 1.22 1.18 1.21 1.21 41,198
Dec 11, 2025 1.19 1.20 1.18 1.20 1.20 25,650
Dec 10, 2025 1.20 1.26 1.20 1.22 1.22 78,257
Dec 9, 2025 1.17 1.20 1.17 1.20 1.20 42,228
Dec 8, 2025 1.19 1.20 1.16 1.19 1.19 28,616
Dec 5, 2025 1.19 1.20 1.18 1.20 1.20 60,254
Dec 4, 2025 1.19 1.20 1.16 1.20 1.20 41,502
Dec 3, 2025 1.16 1.20 1.14 1.17 1.17 25,201
Dec 2, 2025 1.21 1.22 1.17 1.19 1.19 88,625
Dec 1, 2025 1.20 1.25 1.20 1.24 1.24 123,048
Nov 28, 2025 1.08 1.25 1.07 1.20 1.20 122,077
Nov 26, 2025 1.10 1.11 1.08 1.09 1.09 69,170
Nov 25, 2025 1.03 1.11 1.03 1.11 1.11 82,917
Nov 24, 2025 1.07 1.07 1.01 1.03 1.03 138,567
Nov 21, 2025 1.03 1.07 1.03 1.07 1.07 78,378
Nov 20, 2025 1.05 1.07 1.01 1.04 1.04 137,607
Nov 19, 2025 1.04 1.06 1.01 1.04 1.04 35,760
Nov 18, 2025 1.06 1.08 1.02 1.06 1.06 50,713
Nov 17, 2025 1.08 1.08 1.03 1.04 1.04 65,374
Nov 14, 2025 1.09 1.09 1.07 1.07 1.07 65,451
Nov 13, 2025 1.07 1.11 1.06 1.07 1.07 90,680
Nov 12, 2025 1.06 1.10 1.03 1.07 1.07 100,102
Nov 11, 2025 1.07 1.08 1.02 1.02 1.02 202,312
Nov 10, 2025 1.07 1.10 1.05 1.07 1.07 257,194
Nov 7, 2025 1.09 1.16 1.07 1.14 1.14 184,830
Nov 6, 2025 1.09 1.26 1.04 1.16 1.16 594,180
Nov 5, 2025 1.29 1.39 1.04 1.11 1.11 27,013,419
Nov 4, 2025 1.24 1.60 1.07 1.08 1.08 1,130,495
Nov 3, 2025 1.31 1.35 1.25 1.27 1.27 66,068
Oct 31, 2025 1.37 1.38 1.30 1.30 1.30 96,039
Oct 30, 2025 1.50 1.54 1.35 1.35 1.35 100,193
Oct 29, 2025 1.54 1.55 1.43 1.46 1.46 80,352
Oct 28, 2025 1.57 1.58 1.50 1.53 1.53 119,413
Oct 27, 2025 1.67 1.67 1.56 1.57 1.57 89,524
Oct 24, 2025 1.70 1.75 1.64 1.64 1.64 124,497
Oct 23, 2025 1.66 1.82 1.66 1.73 1.73 119,632
Oct 22, 2025 1.67 1.90 1.66 1.74 1.74 354,925
Oct 21, 2025 1.75 1.89 1.64 1.80 1.80 558,869
Oct 20, 2025 2.02 2.14 1.68 1.73 1.73 24,986,430
Oct 17, 2025 1.57 1.58 1.50 1.50 1.50 55,750
Oct 16, 2025 1.61 1.64 1.55 1.57 1.57 38,316
Oct 15, 2025 1.64 1.64 1.55 1.59 1.59 42,586
Oct 14, 2025 1.65 1.65 1.59 1.61 1.61 63,256
Oct 13, 2025 1.70 1.74 1.59 1.63 1.63 119,818
Oct 10, 2025 1.85 1.90 1.69 1.70 1.70 71,258
Oct 9, 2025 1.85 1.97 1.82 1.83 1.83 156,768
Oct 8, 2025 1.92 1.92 1.81 1.82 1.82 80,876
Oct 7, 2025 2.01 2.12 1.85 1.88 1.88 108,530
Oct 6, 2025 2.16 2.16 1.98 1.99 1.99 308,897
Oct 3, 2025 2.19 2.26 1.89 1.90 1.90 228,446
Oct 2, 2025 2.50 2.60 2.13 2.22 2.22 218,234
Oct 1, 2025 2.23 2.61 2.19 2.52 2.52 719,373
Sep 30, 2025 2.34 2.34 2.06 2.17 2.17 666,641
Sep 29, 2025 2.58 2.79 2.01 2.34 2.34 55,783,967
Sep 26, 2025 1.66 1.85 1.66 1.84 1.84 150,811
Sep 25, 2025 1.66 1.67 1.65 1.65 1.65 50,771
Sep 24, 2025 1.67 1.68 1.64 1.67 1.67 16,202

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Redhill Biopharma Ltd. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at RDHL, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation